Abstract
AIM Being diagnosed as Brain Stem Dead is a very challenging experience for families. Most research regarding brain stem death focuses on Organ Donation and there is currently little research into families’ experience of brain stem death. The aim is to review the family’s experience of brain stem death.
DESIGN Systematic review
METHOD A narrative synthesis was conducted for 9 studies including qualitative and quantitative study designs. Four electronic databases: AHMED (Allied and Complimentary Medicine), Emcare (1995-present), Medline (Ovid) and APA Psych Info (Ovid) were searched. No limit was placed on date of publishing due to this being a relatively under researched topic. The original search was conducted on 4th November 2021 and rerun on 6th December 2022 to ensure the inclusion of any new published studies.
RESULTS Six main themes were identified, including: The Unexpected Prognosis; Coming to terms with brain stem death- grieving process; Request for organ donation; Observing brain stem death testing; The impact of staff on families’ experience; and the lasting impact.
CONCLUSION Families of patients with brain stem death are often left with a lack of understanding surrounding the diagnosis, the process, and the short and long term distress it can cause. There is need for research into family’s experiences and brain stem death testing specifically so that more reliable data can be produced. There is a need to establish national, or international practice surrounding family care in intensive care in cases of brain stem death. This review highlights the importance of establishing specific brain stem death protocols, enabling more effective and consistent support for families.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
